All the guidelines mentioned say that the approach toward computerized systems used in clinical practice (e.g., regarding validation) should be risk proportionate.

There are some eternal values in regulated companies’ lives: GCP, 21 CFR Part 11, and computerized systems validation. However, even these are subject to change.
Recently the most important of them have been updated:
And we can add the well-acknowledged guidance to this list: GAMP®5: 2021 Good Practice Guide: Enabling Innovation.
The changed regulations do influence all of us involved in clinical trials. To make business processes sustainable, there’s an industry trend in place: to adopt a risk-based approach. All the guidelines mentioned say that the approach toward computerized systems used in clinical practice (e.g., regarding validation) should be risk proportionate.
Considerations when applying a risk-based approach for the validation of electronic systems include the following:
And here is the question that was touched upon by our QA Director during the RQA Conference: to which extent might it be reasonable to leverage the CSV-related activities to the vendor?
In general, there are two major approaches to it.
What is our standpoint here?
Here at Flex Databases, we base everything on fundamental priorities, the same as always:
If the computerized system you are going to use does not influence these, considering minimizing the validation efforts might be a good idea. However, it doesn’t mean not validating the system at all. As the system owner is responsible for everything, the approach, process, and outcome must be documented.
All the guidelines say that vendor-provided documents and services can be used. Here’s the list of what can be leveraged to the vendor:
To make your vendor the trusted one, ensure that you have qualified it, and here’s what is to be assessed:
Once you have assessed the vendor and signed the contract, any service can be used, including the UAT, if you are sure, it covers exactly what you will use. However, for high-risk systems, the end users are highly recommended to perform UAT themselves to ensure they know how it all works.
If you’d like to start using the software development vendor, here’s the short checklist of questions to answer before you begin the process to make it easier and more targeted:
Implementing a risk-based approach to your eClinical systems validation might look like a lot of work, but with the right vendor you can minimize your efforts while maximizing quality and sustainability of your business processes. If you want to learn more – contact us at bd@flexdatabases.com
Tell us more about yourself and we will organize a tailored live demo to show how you can power up your clinical trials processes with Flex Databases.